dalteparin has been researched along with Hypertension, Pulmonary in 8 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the efficacy, safety and relation of dose to plasma anti-Xa activity of the low molecular weight heparin (LMWH) dalteparin in prophylaxis and therapy of arterial and venous thrombosis in pediatric patients." | 7.70 | The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases. ( Auberger, K; Flemmer, A; Nohe, N; Praun, M; Rümler, R, 1999) |
| " Here, rivaroxaban, an oral, direct factor Xa (FXa) inhibitor, was compared with warfarin and enoxaparin in the prevention of right ventricular (RV) dysfunction and hypertrophy in the monocrotaline (MCT) model of pulmonary hypertension." | 3.77 | A role for coagulation factor Xa in experimental pulmonary arterial hypertension. ( Delbeck, M; Ellinghaus, P; Kast, R; Laux, V; Nickel, KF; Perzborn, E; Schäfer, S; Schermuly, RT; Strassburger, J; von Degenfeld, G, 2011) |
| "We investigated the efficacy, safety and relation of dose to plasma anti-Xa activity of the low molecular weight heparin (LMWH) dalteparin in prophylaxis and therapy of arterial and venous thrombosis in pediatric patients." | 3.70 | The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases. ( Auberger, K; Flemmer, A; Nohe, N; Praun, M; Rümler, R, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chazova, IE | 1 |
| Panchenko, EP | 1 |
| Dobrovol'skiĭ, AB | 1 |
| Nakonechnikov, SN | 1 |
| Titaeva, EV | 1 |
| Baklanova, NA | 1 |
| Belenkov, IuN | 1 |
| Rosengarten, D | 1 |
| Kramer, R | 1 |
| Delbeck, M | 1 |
| Nickel, KF | 1 |
| Perzborn, E | 1 |
| Ellinghaus, P | 1 |
| Strassburger, J | 1 |
| Kast, R | 1 |
| Laux, V | 1 |
| Schäfer, S | 1 |
| Schermuly, RT | 1 |
| von Degenfeld, G | 1 |
| Smith, JS | 1 |
| Mueller, J | 1 |
| Daniels, CJ | 1 |
| Ng, WP | 1 |
| Yip, WL | 1 |
| Elidemir, O | 1 |
| Smith, KJ | 1 |
| Schecter, MG | 1 |
| Seethamraju, H | 1 |
| Mahoney, DH | 1 |
| McKenzie, ED | 1 |
| Mallory, GB | 1 |
| Xiang, Y | 1 |
| Li, J | 1 |
| Sun, Y | 1 |
| Nohe, N | 1 |
| Flemmer, A | 1 |
| Rümler, R | 1 |
| Praun, M | 1 |
| Auberger, K | 1 |
8 other studies available for dalteparin and Hypertension, Pulmonary
| Article | Year |
|---|---|
[The effect of long-term Fraxiparin treatment on hemostasis in patients with primary pulmonary hypertension].
Topics: Adult; Anticoagulants; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Hemostas | 1997 |
Pregnancy in a woman with pulmonary hypertension: favorable outcome with intravenous treprostinil.
Topics: Adult; Anticoagulants; Antihypertensive Agents; Cesarean Section; Enoxaparin; Epoprostenol; Female; | 2015 |
A role for coagulation factor Xa in experimental pulmonary arterial hypertension.
Topics: Animals; Blood Coagulation; Enoxaparin; Factor Xa; Factor Xa Inhibitors; Familial Primary Pulmonary | 2011 |
Pulmonary arterial hypertension in the setting of pregnancy: a case series and standard treatment approach.
Topics: Adult; Algorithms; Anticoagulants; Antihypertensive Agents; Bosentan; Enoxaparin; Epoprostenol; Fema | 2012 |
Successful maternal-foetal outcome using nitric oxide and sildenafil in pulmonary hypertension with atrial septal defect and HIV infection.
Topics: Anti-HIV Agents; Anticoagulants; Enoxaparin; Female; Heart Septal Defects, Atrial; HIV Infections; H | 2012 |
Lung transplantation in a patient with a thrombophilic disorder.
Topics: Adult; Cystic Fibrosis; Enoxaparin; Fatal Outcome; Female; Heparin; Heterozygote; Humans; Hypertensi | 2008 |
A case report of pulmonary arterial hypertension in pregnancy and complications of anticoagulation therapy.
Topics: Adult; Anticoagulants; Antihypertensive Agents; Cardiovascular Agents; Dalteparin; Epoprostenol; Fem | 2018 |
The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases.
Topics: Adolescent; Age Factors; Anticoagulants; Child; Child, Preschool; Dalteparin; Dose-Response Relation | 1999 |